Evidence map›Paper›PMID 40603307›Full record

ArticleCell death & disease2025

Editorial Expression of Concern to: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133

V Tirino, R Camerlingo, K Bifulco, E Irollo, R Montella, F Paino, G Sessa, M V Carriero, N Normanno, G Rocco and 1 more

Abstract readExpression of Concern
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

V TirinoDepartment of Experimental Medicine, Second University of Naples, Naples, Italy.
R CamerlingoDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy.
K BifulcoDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy.
E IrolloDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy.
R MontellaDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy.
F PainoDepartment of Experimental Medicine, Second University of Naples, Naples, Italy.
G SessaDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy.
M V CarrieroDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy.
N NormannoDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy.
G RoccoDepartment of Thoracic Surgery and Oncology, National Cancer Institute, Naples, Italy.
G PirozziDepartment of Experimental Oncology, National Cancer Institute, Naples, Italy. g.pirozzi@istitutotumori.na.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40603307
PMCPMC12222770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.